World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
19515
World Ranking
2730
National Ranking
1301

Spyros A. Kalams publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Spyros A. Kalams sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 168 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Spyros A. Kalams D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Spyros A. Kalams sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Spyros A. Kalams is affiliated with Vanderbilt University Medical Center in the United States and has contributed extensively to the fields of Medicine and Immunology and Microbiology. Their research spans several subfields, including Immunology, Epidemiology, Infectious Diseases, Virology, and Emergency Medicine.

The scientist's research covers a range of main topics, with a notable focus on HIV research and treatment. Additional principal areas include immune cell function and interaction, HIV-related health complications and treatments, influenza virus research studies, SARS-CoV-2 and COVID-19 research, adipokines, inflammation, and metabolic diseases, as well as respiratory viral infections research.

Kalams has coauthored works frequently with several researchers, including S. Mallal, Samuel Bailin, Celestine N. Wanjalla, Joshua D. Simmons, and Mona Mashayekhi.

Their recent contributions to scientific literature include:

  • Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial, 2022, Science
  • Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial, 2021, bioRxiv (Cold Spring Harbor Laboratory)
  • Robust antibody and cellular responses induced by DNA-only vaccination for HIV, 2020, JCI Insight
  • Single-cell analysis shows that adipose tissue of persons with both HIV and diabetes is enriched for clonal, cytotoxic, and CMV-specific CD4+ T cells, 2021, Cell Reports Medicine
  • Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls, 2021, Transplant Infectious Disease

Kalams' research has appeared frequently in specific publication venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • SSRN Electronic Journal
  • Journal of the Endocrine Society
  • Journal of Virology

Best Publications

  • Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

    Eric S. Rosenberg;James M. Billingsley;Angela M. Caliendo;Steven L. Boswell

  • HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes

    Kathleen L. Collins;Benjamin K. Chen;Spyros A. Kalams;Spyros A. Kalams;Bruce D. Walker;Bruce D. Walker

  • Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.

    Peter B Gilbert;Peter B Gilbert;David C Montefiori;Adrian B McDermott;Youyi Fong

  • The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses

    Spyros A. Kalams;Bruce D. Walker

  • Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection

    D. Noah Sather;Jakob Armann;Jakob Armann;Lance K. Ching;Lance K. Ching;Angeliki Mavrantoni;Angeliki Mavrantoni

  • Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

    T Harrer;E Harrer;S A Kalams;P Barbosa

  • Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection.

    Spyros A. Kalams;S. P. Buchbinder;E. S. Rosenberg;J. M. Billingsley

  • Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.

    Spyros A. Kalams;Philip J. Goulder;Amy K. Shea;Norman G. Jones

  • Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans.

    Ludwig Wagner;Otto O. Yang;Eduardo A. Garcia-Zepeda;Yimin Ge

  • Strong Cytotoxic T Cell and Weak Neutralizing Antibody Responses in a Subset of Persons with Stable Nonprogressing HIV Type 1 Infection

    Thomas Harrer;Ellen Harrer;Spyros A. Kalams;Tarek Elbeik

  • Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms.

    O O Yang;S A Kalams;A Trocha;H Cao

  • Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1

    Iliyana Mikell;D. Noah Sather;Spyros A. Kalams;Marcus Altfeld

  • DC-Dielectrophoretic separation of biological cells by size

    Yuejun Kang;Dongqing Li;Spyros A. Kalams;Josiane E. Eid

  • Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity

    Pedro O. Flores-Villanueva;Edmond J. Yunis;Julio C. Delgado;Eric Vittinghoff

  • Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.

    Philip J.R. Goulder;Philip J.R. Goulder;Marcus A. Altfeld;Eric S. Rosenberg;Thi Nguyen

  • Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines

    R. I. Connor;B. T. M. Korber;B. S. Graham;B. H. Hahn

  • Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

    O O Yang;S A Kalams;M Rosenzweig;A Trocha

  • Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

    Spyros A. Kalams;Scott D. Parker;Marnie Elizaga;Barbara Metch

  • Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.

    S A Kalams;R P Johnson;A K Trocha;M J Dynan

  • Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape

    Dirk Meyer-Olson;Naglaa H. Shoukry;Kristen W. Brady;Helen Kim

Frequent Co-Authors

Bruce D. Walker
Bruce D. Walker Harvard University
Simon Mallal
Simon Mallal Vanderbilt University Medical Center
Alicja Trocha
Alicja Trocha Ragon Institute of MGH, MIT and Harvard
Silvana Gaudieri
Silvana Gaudieri University of Western Australia
Philip J. R. Goulder
Philip J. R. Goulder University of Oxford
Stephen C. De Rosa
Stephen C. De Rosa Fred Hutchinson Cancer Research Center
Susan Buchbinder
Susan Buchbinder University of California, San Francisco
Marcus Altfeld
Marcus Altfeld University Medical Center Hamburg-Eppendorf
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Eric S. Rosenberg
Eric S. Rosenberg Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Many professionals begin with foundational roles, such as Licensed Practical Nurse (LPN), which can be accessed through programs recognized for being easy to enter. Finding the right program can make a significant difference, and resources highlighting lpn programs easy to get into can help guide your decision.

Advancing your career may involve pursuing a Family Nurse Practitioner (FNP) degree. Some institutions offer streamlined options focused on accessibility and flexibility. Those considering this route should review lists of the easiest fnp program options available online to balance convenience and quality education.

For those passionate about mental health within immunology and nursing, specialized training such as the Psychiatric Mental Health Nurse Practitioner (PMHNP) is an impactful choice. Seeking programs with superior clinical placement opportunities is essential for hands-on experience. The top pmhnp programs provide valuable insights into schools excelling in this area.

Cost can often be a barrier, but affordable education pathways do exist. Many aspiring nurse practitioners benefit from exploring the cheapest online pmhnp certificate programs that balance affordability with comprehensive curriculum. This approach helps students gain essential skills without incurring excessive debt.

Best Scientists Citing Spyros A. Kalams

Trending Scientists

Recently Published Articles